|Articles|January 24, 2019
Pharmacy Practice in Focus: Health Systems
- January 2019
- Volume 8
- Issue 1
Progress in Treating Advanced Melanoma: Pharmacists
In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).
Advertisement
FACULTY:
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, Clinical Associate Professor, University of South Carolina College of Pharmacy, Columbia, South Carolina
EDUCATIONAL OBJECTIVES:
At the completion of this activity, the participant will be able to:
- Identify the treatment options for patients with advanced melanoma
- Examine the latest clinical data for patients with advanced melanoma
- Explain the role of the pharmacist in supporting optimal treatment strategies in advanced melanoma management
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: December 28, 2018
EXPIRATION DATE: January 12, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at
Articles in this issue
over 7 years ago
What Are Treatment Approaches to Liver Cancer?over 7 years ago
What Are the Implications of the MERINO Trial?over 7 years ago
Develop a Collaborative Pain Management Strategyover 7 years ago
Are You the Gentamicin Pharmacist?Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
5